4.4 Article

Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β

期刊

BMC NEUROLOGY
卷 16, 期 -, 页码 -

出版社

BIOMED CENTRAL LTD
DOI: 10.1186/s12883-016-0707-z

关键词

Neuroinflammation; Cytokines; Alzheimer's disease

资金

  1. Boehringer Ingelheim Ulm University BioCenter (BIU)
  2. Ernst Schering foundation

向作者/读者索取更多资源

Background: It is widely accepted that neuroinflammatory processes play an important role in the pathogenesis of Alzheimer's disease (AD) and high levels of cytokines and chemokines are detected around A beta plaques. Methods: As neuroinflammation is involved in the development and progression of AD, we measured the pro-inflammatory cytokines interleukin 1 beta (IL-1 beta), IL-8 and tumor necrosis factor a (TNF-alpha) in serum and cerebrospinal fluid (CSF) samples from 45 AD patients and 53 age-matched control subjects using a highly sensitive multiplex electrochemiluminescence assay. To address the association with disease progression we correlated cognitive status with cytokine levels. Results: CSF as well as serum IL-8 levels were found to be significantly lower in AD patients than in controls (p = 0.02). A statistically significant inverse correlation was observed between the CSF level of IL-1 beta and the MMSE score (rs = -0.03, p = 0.02). We therefore stratified the AD patients by their MMSE scores into three equal groups and found that in the AD group with the most severe cognitive impairment CSF-IL-1 beta was significantly increased compared to age-matched controls (p < 0.05), whereas in the other investigated groups the increase was not statistically significant. Conclusion: Our results confirm data suggesting that cytokine alterations are involved in AD pathogenesis and may be helpful as a biomarker for monitoring disease progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease

Lorenzo Barba, Samir Abu Rumeileh, Giovanni Bellomo, Federico Paolini Paoletti, Steffen Halbgebauer, Patrick Oeckl, Petra Steinacker, Federico Massa, Lorenzo Gaetani, Lucilla Parnetti, Markus Otto

Summary: This study found that beta-syn levels in cerebrospinal fluid (CSF) increase in patients with Alzheimer's disease (AD) in the mild cognitive impairment (MCI) and dementia stages. In contrast, the behavior of other synaptic biomarkers, such as alpha-syn, and biomarkers of neuro-axonal damage, such as NfL and t-tau, is different. CSF beta-syn has the best diagnostic performance for distinguishing pre-AD patients from non-AD patients.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Clinical Neurology

Neuronal loss of the nucleus basalis of Meynert in primary progressive aphasia is associated with Alzheimer's disease neuropathological changes

Jolien Schaeverbeke, Sandra O. Tome, Alicja Ronisz, Simona Ospitalieri, Christine A. F. von Arnim, Markus Otto, Rik Vandenberghe, Dietmar Rudolf Thal

Summary: This study quantitatively assessed neuronal density and pathology in the nucleus basalis of Meynert (nbM) of 47 cases, including different variants of primary progressive aphasia (PPA) and Alzheimer's disease (AD). The results showed that reduced nbM neuronal density was only found in AD. PPA patients with underlying AD pathology exhibited lower neuronal densities, while those with frontotemporal lobar degeneration (FTLD) were unaffected.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Relationship of serum beta-synuclein with blood biomarkers and brain atrophy

Patrick Oeckl, Sarah Anderl-Straub, Adrian Danek, Janine Diehl-Schmid, Klaus Fassbender, Klaus Fliessbach, Steffen Halbgebauer, Hans-Juergen Huppertz, Holger Jahn, Jan Kassubek, Johannes Kornhuber, Bernhard Landwehrmeyer, Martin Lauer, Johannes Prudlo, Anja Schneider, Matthias L. Schroeter, Petra Steinacker, Alexander E. Volk, Matias Wagner, Juliane Winkelmann, Jens Wiltfang, Albert C. Ludolph, Markus Otto

Summary: Recent data support beta-synuclein as a blood biomarker for studying synaptic degeneration in Alzheimer's disease. This study compared serum beta-synuclein with established blood markers (p-tau181 and NfL) and found that beta-synuclein is increased in AD and correlated with temporal brain atrophy and cognitive impairment. The pattern of beta-synuclein changes differs from p-tau181 and NfL.

ALZHEIMERS & DEMENTIA (2023)

Review Clinical Neurology

The multifaceted role of neurofilament light chain protein in non-primary neurological diseases

Samir Abu-Rumeileh, Ahmed Abdelhak, Matteo Foschi, Lucio D'Anna, Michele Russo, Petra Steinacker, Jens Kuhle, Hayrettin Tumani, Kaj Blennow, Markus Otto

Summary: Abu-Rumeileh et al. provide an overview of the role of neurofilament light chain protein as a biomarker in various medical fields. Its validation and application have greatly impacted the diagnosis and prognosis of neurological diseases. Recent studies have also explored its potential applications in non-primary neurological conditions.
Article Clinical Neurology

Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

David J. Whiteside, Maura Malpetti, P. Simon Jones, Boyd C. P. Ghosh, Ian Coyle-Gilchrist, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Robert Laforce, Caroline Graff, Matthis Synofzik, Daniela Galimberti, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, Alexandre de Mendonca, Fabrizio Tagliavini, Chris R. Butler, Isabel Santana, Isabelle Le Ber, Alexander Gerhard, Simon Ducharme, Johannes Levin, Adrian Danek, Markus Otto, Sandro Sorbi, Florence Pasquier, Arabella Bouzigues, Lucy L. Russell, Jonathan D. Rohrer, James B. Rowe, Timothy Rittman

Summary: This study investigated the role of changes in functional networks in predicting cognitive decline and conversion to symptomatic disease in familial frontotemporal dementia (FTD). The study found a characteristic pattern of dynamic network changes in FTD, which were correlated with neuropsychological impairment. Among presymptomatic mutation carriers, this pattern of network dynamics was more prominent in those who later converted to the symptomatic phase. Baseline network dynamic changes predicted future cognitive decline in symptomatic participants and older presymptomatic participants.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers

Elizabeth Finger, Rubina Malik, Martina Bocchetta, Kristy Coleman, Caroline Graff, Barbara Borroni, Mario Masellis, Robert Laforce, Caroline Greaves, Lucy L. Russell, Rhian S. Convery, Arabella Bouzigues, David M. Cash, Markus Otto, Matthis Synofzik, James B. Rowe, Daniela Galimberti, Pietro Tiraboschi, Robert Bartha, Christen Shoesmith, Maria Carmela Tartaglia, John C. van Swieten, Harro Seelaar, Lize C. Jiskoot, Sandro Sorbi, Chris R. Butler, Alexander Gerhard, Raquel Sanchez-Valle, Alexandre de Mendonca, Fermin Moreno, Rik Vandenberghe, Isabelle Le Ber, Johannes Levin, Florence Pasquier, Isabel Santana, Jonathan D. Rohrer, Simon Ducharme

Summary: This study investigates the hypothesis that genetic mutations causing frontotemporal dementia (FTD) have neurodevelopmental consequences. The researchers examined brain structure and function in young adult mutation carriers and found differences between preclinical mutation carriers and familial non-carriers at a mean age of 26 years. These findings have implications for therapeutic interventions and further studies on early pathophysiologic processes in FTD.
Article Clinical Neurology

Language impairment in the genetic forms of behavioural variant frontotemporal dementia

Kiran Samra, Amy M. MacDougall, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, John C. van Swieten, Harro Seelaar, Lize Jiskoot, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Christopher R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan D. Rohrer, Lucy L. Russell

Summary: The study found that about 76% of patients with genetic bvFTD have language impairments, characterized by impaired functional communication, decreased fluency, and impaired sentence comprehension. There are differences in the extent of brain atrophy in specific language regions and language symptoms among different genetic types of patients. This research is helpful for further understanding the language phenotype associated with genetic bvFTD, especially in accurate stratification and monitoring of disease progression in clinical trials.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

A novel homozygous p.Ser69Pro SOD1 mutation causes severe young-onset ALS with decreased enzyme activity

Nagia Fahmy, Kathrin Mueller, Peter Munch Andersen, Stefan L. Marklund, Markus Otto, Albert C. Ludolph, Nabila Hamdi

Summary: This study reports a rare case of homozygous SOD1 mutation leading to early onset and severe lower motor neuron-dominant ALS. The mutation resulted in decreased enzymatic activity and the patient exhibited significantly elevated serum neurofilament light chain levels.

JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

The Benson Complex Figure Test detects deficits in visuoconstruction and visual memory in symptomatic familial frontotemporal dementia: A GENFI study

Lize C. Jiskoot, Lucy L. Russell, Georgia Peakman, Rhian S. Convery, Caroline V. Greaves, Martina Bocchetta, Jackie M. Poos, Harro Seelaar, Lucia A. A. Giannini, John C. van Swieten, Rick van Minkelen, Yolande A. L. Pijnenburg, James B. Rowe, Barbara Borroni, Daniela Galimberti, Mario Masellis, Carmela Tartaglia, Elizabeth Finger, Chris R. Butler, Caroline Graff, Robert Laforce Jr, Raquel Sanchez-Valle, Alexandre de Mendonca, Fermin Moreno, Matthis Synofzik, Rik Vandenberghe, Simon Ducharme, Isabelle le Ber, Johannes Levin, Markus Otto, Florence Pasquier, Isabel Santana, David M. Cash, David Thomas, Jonathan D. Rohrer

Summary: The Benson Complex Figure Test (BCFT) shows potential as a sensitive cognitive marker for frontotemporal dementia (FTD). Differences were found in BCFT Copy, Recall, and Recognition scores between presymptomatic and symptomatic FTD mutation carriers, with correlations to cognitive function and neuroimaging results. These findings suggest limited potential of BCFT as a cognitive biomarker for upcoming clinical trials in presymptomatic to early-stage FTD.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

Lorenzo Barba, Samir Abu-Rumeileh, Steffen Halbgebauer, Giovanni Bellomo, Federico Paolini Paoletti, Lorenzo Gaetani, Patrick Oeckl, Petra Steinacker, Federico Massa, Lucilla Parnetti, Markus Otto

Summary: This study aimed to investigate the correlation between CSF biomarkers and the presence of AD copathology in LBD patients and determine their usefulness in differentiating LBD patients with different AT(N) profiles. The results showed that CSF levels of synaptic and neuroaxonal damage biomarkers were significantly increased in AD patients compared to LBD patients and controls. Among LBD patients, those with A+T+ profiles had higher levels of biomarkers for synaptic and neuroaxonal degeneration compared to those with A-T- profiles.

NEUROLOGY (2023)

Article Clinical Neurology

Structural correlates of language processing in primary progressive aphasia

Curtiss A. Chapman, Maryna Polyakova, Karsten Mueller, Christopher Weise, Klaus Fassbender, Klaus Fliessbach, Johannes Kornhuber, Martin Lauer, Sarah Anderl-Straub, Albert Ludolph, Johannes Prudlo, Anja Staiger, Matthis Synofzik, Jens Wiltfang, Lina Riedl, Janine Diehl-Schmid, Markus Otto, Adrian Danek, Gesa Hartwigsen, Matthias L. Schroeter

Summary: Understanding the relationship between brain structure and language behavior in primary progressive aphasia is crucial for understanding the pathomechanisms of these diseases. This study found that there are networks of language task-associated brain regions, some of which show atrophy and others do not, suggesting regions of future network disruption and providing insights into task deficits beyond atrophied cortex.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia

Kiran Samra, Amy M. MacDougall, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, Chris Hardy, John C. van Swieten, Harro Seelaar, Lize C. Jiskoot, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Chris R. Butler, Alexander Gerhard, Simon Ducharme, Isabelle Le Ber, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jason D. Warren, Jonathan D. Rohrer, Lucy L. Russell

Summary: Samra et al. report that progranulin mutations are the most common genetic cause of primary progressive aphasia, with two subtypes observed. Revised criteria for primary progressive aphasia should take into account genetic phenotypes. Primary progressive aphasia is typically sporadic, but can also be genetic.

BRAIN COMMUNICATIONS (2023)

Article Clinical Neurology

Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort

Kiran Samra, Amy M. MacDougall, Arabella Bouzigues, Martina Bocchetta, David M. Cash, Caroline Greaves, Rhian S. Convery, John C. van Swieten, Lize Jiskoot, Harro Seelaar, Fermin Moreno, Raquel Sanchez-Valle, Robert Laforce, Caroline Graff, Mario Masellis, Maria Carmela Tartaglia, James B. Rowe, Barbara Borroni, Elizabeth Finger, Matthis Synofzik, Daniela Galimberti, Rik Vandenberghe, Alexandre de Mendonca, Chris R. Butler, Alex Gerhard, Simon Ducharme, Isabelle Le Ber, Pietro Tiraboschi, Isabel Santana, Florence Pasquier, Johannes Levin, Markus Otto, Sandro Sorbi, Jonathan D. Rohrer, Lucy L. Russell

Summary: This study aimed to determine whether language impairment exists presymptomatically in genetic FTD and to identify key differences between different genetic mutation groups. The study found that language deficits were present in 3% of asymptomatic and 48% of prodromal mutation carriers. Impaired word retrieval, grammar/syntax, fluency, and articulation were observed in prodromal mutation carriers, with variations between different genetic groups. Regional brain volume atrophy also differed between groups.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Article Clinical Neurology

Longitudinal course of neurofilament light chain levels in amyotrophic lateral sclerosis-insights from a completed randomized controlled trial with rasagiline

Simon Witzel, Jeffrey M. Statland, Petra Steinacker, Markus Otto, Johannes Dorst, Joachim Schuster, Richard J. Barohn, Albert C. Ludolph

Summary: Rasagiline may have an effect on disease modification in patients with amyotrophic lateral sclerosis (ALS), and neurofilament light chain (NfL) could be a potential biomarker in ALS. Further studies are needed to differentiate NfL response to treatment from other factors.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Meeting Abstract Clinical Neurology

Incidence of syndromes associated with Frontotemporal Lobar Degeneration

Giancarlo Logroscino, Marco Piccininni, Caroline Graff, Orla Hardiman, Albert Ludolph, Fermin Moreno, Markus Otto, Anne Remes, James Rowe, Harro Seelaar, Eino Solje, Elka Stefanova, Latchezar Traykov, Vesna Jelic, Melissa Thaeri Rydell, Niall Pender, Sarah Anderl-Straub, Myriam Barandiaran, Alazne Gabilondo, Johanna Kruger, Alexander Murley, Timothy Rittman, Emma L. Van der Ende, John Van Swieten, Paivi Hartikainen, Gorana Mandic Stojmenovic, Shima Meherabian, Luisa Benussi, Antonella Alberici, Maria Teresa Dell'Abate, Chiara Zecca, Barbara Borroni

NEUROLOGY (2023)

暂无数据